Novo Nordisk Introduction

In Novo Nordisk, we are driving change to defeat diabetes and other serious chronic conditions.

Diabetes poses one of today’s biggest global health challenges. We work for a future where fewer people get diabetes, everyone with diabetes is diagnosed, and everyone who is diagnosed receives adequate treatment and can live a life with as few limitations as possible.

Since the company was founded in Denmark more than 90 years ago, we have been changing diabetes. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. Our ambition is to take the lead in each of these areas, driving change with an unfailing belief that it can be done.

Our key contribution is to discover and develop better biological medicines, manufacture them to meet increasing global demand and make them accessible wherever they are needed. We are committed to finding the next generation of medicines and long-term investments in innovation have made us experts in the field of modern biotechnology.

Producing life-saving medicines is a significant responsibility: millions of people depend on us. However, to defeat a serious chronic condition, we need to do more than supply the right medicine. This is why we work in partnerships with patients, policymakers, healthcare professionals and non-governmental organisations to raise awareness, improve prevention, promote earlier diagnosis and expand access to care.

We have built our business on the conviction that the formula for lasting success is to stay focused, think long-term and do business in a financially, socially and environmentally responsible way.